𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High hepatitis C incidence in new injecting drug users: a policy failure?

✍ Scribed by Lisa Maher; Jiong Li; Bin Jalaludin; Kerry G. Chant; John M. Kaldor

Book ID
109381858
Publisher
Public Health Association of Australia
Year
2007
Tongue
English
Weight
104 KB
Volume
31
Category
Article
ISSN
1326-0200

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High incidence of hepatitis C virus rein
High incidence of hepatitis C virus reinfection in a cohort of injecting drug users
✍ Campbell Kynoch Aitken; Jennifer Lewis; Samantha Lilly Tracy; Timothy Spelman; D πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 160 KB πŸ‘ 2 views

An estimated 170 million people worldwide carry the hepatitis C virus (HCV), and in more developed countries the prevalence and incidence of HCV is particularly high among injecting drug users (IDUs). Spontaneous clearance of HCV infection and reinfection is well recognized but the level of protecti

Failure to diagnose recent hepatitis C v
Failure to diagnose recent hepatitis C virus infections in London injecting drug users
✍ Emma Aarons; Paul Grant; Kate Soldan; Pete Luton; Julian Tang; Richard Tedder πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract Hepatitis C virus (HCV) infection results in chronic liver disease in a substantial proportion of those infected. Most new cases of HCV infection in the UK are associated with intravenous drug use. It is important to identify these infections because of the implications for the future h

Molecular epidemiology of hepatitis C vi
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users
✍ Yoann Morice; Jean-FranΓ§ois Cantaloube; StΓ©phanie Beaucourt; Laetitia Barbotte; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract Hepatitis C virus subtype 3a (HCV‐3a) originates from Asia and has spread widely among injecting drug users as well as other patient groups in industrialized countries. HCV subtype 3a infection remains highly prevalent and frequently transmitted in the population of intravenous drug use